Correlation Between Ionis Pharmaceuticals and Apellis Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Ionis Pharmaceuticals and Apellis Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ionis Pharmaceuticals and Apellis Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ionis Pharmaceuticals and Apellis Pharmaceuticals, you can compare the effects of market volatilities on Ionis Pharmaceuticals and Apellis Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ionis Pharmaceuticals with a short position of Apellis Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ionis Pharmaceuticals and Apellis Pharmaceuticals.
Diversification Opportunities for Ionis Pharmaceuticals and Apellis Pharmaceuticals
0.79 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Ionis and Apellis is 0.79. Overlapping area represents the amount of risk that can be diversified away by holding Ionis Pharmaceuticals and Apellis Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Apellis Pharmaceuticals and Ionis Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ionis Pharmaceuticals are associated (or correlated) with Apellis Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Apellis Pharmaceuticals has no effect on the direction of Ionis Pharmaceuticals i.e., Ionis Pharmaceuticals and Apellis Pharmaceuticals go up and down completely randomly.
Pair Corralation between Ionis Pharmaceuticals and Apellis Pharmaceuticals
Given the investment horizon of 90 days Ionis Pharmaceuticals is expected to under-perform the Apellis Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Ionis Pharmaceuticals is 1.6 times less risky than Apellis Pharmaceuticals. The stock trades about -0.14 of its potential returns per unit of risk. The Apellis Pharmaceuticals is currently generating about 0.24 of returns per unit of risk over similar time horizon. If you would invest 2,771 in Apellis Pharmaceuticals on August 31, 2024 and sell it today you would earn a total of 643.00 from holding Apellis Pharmaceuticals or generate 23.2% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Ionis Pharmaceuticals vs. Apellis Pharmaceuticals
Performance |
| Timeline |
| Ionis Pharmaceuticals |
| Apellis Pharmaceuticals |
Ionis Pharmaceuticals and Apellis Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Ionis Pharmaceuticals and Apellis Pharmaceuticals
The main advantage of trading using opposite Ionis Pharmaceuticals and Apellis Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ionis Pharmaceuticals position performs unexpectedly, Apellis Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Apellis Pharmaceuticals will offset losses from the drop in Apellis Pharmaceuticals' long position.| Ionis Pharmaceuticals vs. Arrowhead Pharmaceuticals | Ionis Pharmaceuticals vs. Biomarin Pharmaceutical | Ionis Pharmaceuticals vs. Incyte | Ionis Pharmaceuticals vs. Apellis Pharmaceuticals |
| Apellis Pharmaceuticals vs. Cue Biopharma | Apellis Pharmaceuticals vs. Tff Pharmaceuticals | Apellis Pharmaceuticals vs. Eliem Therapeutics | Apellis Pharmaceuticals vs. Inhibrx |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Other Complementary Tools
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |